Rita Medical Systems Appoints Stonefield Josephson, Inc. as New Independent Auditor

July 5, 2005 at 12:00 AM EDT
Rita Medical Systems Appoints Stonefield Josephson, Inc. as New Independent Auditor

FREMONT, Calif., July 5, 2005 /PRNewswire-FirstCall via COMTEX/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that the Audit Committee of its Board of Directors has engaged the auditing firm of Stonefield Josephson, Inc. as the Company's new independent registered public accounting firm for the year ending December 31, 2005.

Stonefield Josephson, Inc. is a California-based certified public accounting and business advisory firm founded in 1975. The full-service firm serves public and privately held clients throughout the United States and internationally. Stonefield Josephson (www.sjaccounting.com) offers a wide array of services tailored to the special requirements of public companies and their boards of directors and is America's ninth-fastest growing auditor, according to the April 2005 Accounting Report by Art Bowman.

About RITA Medical Systems, Inc.

RITA Medical Systems develops, manufactures and markets innovative products for cancer patients including radiofrequency ablation (RFA) systems for treating cancerous tumors as well as percutaneous vascular and spinal access systems. The Company's oncology product lines include implantable ports, some of which feature its proprietary Vortex® technology; tunneled central venous catheters; safety infusion sets and peripherally inserted central catheters used primarily in cancer treatment protocols. The proprietary RITA system uses radiofrequency energy to heat tissue to a high enough temperature to ablate it or cause cell death. In March 2000, RITA became the first RFA Company to receive specific FDA clearance for unresectable liver lesions in addition to its previous general FDA clearance for the ablation of soft tissue. In October 2002, RITA again became the first company to receive specific FDA clearance, this time, for the palliation of pain associated with metastatic lesions involving bone. The RITA Medical Systems website is at www.ritamedical.com.

The statements in this news release are not intended to predict the Company's future and financial operating performance. Information regarding risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements is included in the Company's filings with the Securities and Exchange Commission.

SOURCE RITA Medical Systems, Inc.

Investors: Doug Sherk